Your provider mentions retatrutide as the next-generation GLP-1 drug, and you want to know how it stacks up against the tirzepatide prescription already in your fridge
Warning Signs That Should Not Be Ignored Serious side effects are less common than nausea or constipation, but they are the most important to recognize
It is not approved for human or veterinary use and is not intended for diagnostic, therapeutic, or clinical applications
It is usually mild, but it should be monitored, especially in people with heart disease
FOR HEADACHE SOURCE: DailyMed
If you would like to learn more about GLP-1 medications or want to see if you might be eligible for medication-assisted weight loss, check out Mochi Health, where board-certified obesity medicine physicians can offer expertise in this realm